Oral Bruton tyrosine kinase inhibitors block activation of the platelet Fc receptor CD32a (FcγRIIA): a new option in HIT?

Autor: Goldmann, Luise, Duan, Rundan, Kragh, Thorsten, Wittmann, Georg, Weber, Christian, Lorenz, Reinhard, von Hundelshausen, Philipp, Spannagl, Michael, Siess, Wolfgang
Zdroj: In Blood Advances 10 December 2019 3(23):4021-4033
Databáze: ScienceDirect